Mannheimia haemolytica (Newsom and Cross) Angen et al.
商品貨號
B174899
Deposited As
Pasteurella haemolytica Newsom and Cross
Strain Designations
76-72H (Vaccine)
Application
Used to produce vaccine against Pasteurella haemolytica
Isolation
Derived from existing strain
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Kucera CJ. Modified Pasteurella bacteria and vaccines prepared therefrom. US Patent 4,388,299 dated Jun 14 1983
Kucera CJ. Modified Pasteurella haemolytica bacteria. US Patent 4,506,017 dated Mar 19 1985
Kucera CJ. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom. US Patent 4,626,430 dated Dec 2 1986
